Literature DB >> 10884918

p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women.

K Servomaa1, A Kiuru, V M Kosma, P Hirvikoski, T Rytömaa.   

Abstract

AIMS/
BACKGROUND: The aim of this study was to identify p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women. Mutation patterns might give clues to aetiological factors when comparisons are made with other human tumours.
METHODS: Of 134 women with carcinoma of the rectum, paraffin wax embedded specimens of the tumour tissue were obtained from 118 patients. Genomic DNA was extracted, and exons 4-8 of the p53 gene and codons 12/13 and 61 of the K-ras gene were amplified, and analysed for mutations by single strand conformation polymorphism and direct sequencing. The production of p53 and K-ras proteins was studied by immunohistochemistry.
RESULTS: The overall crude frequency for mutations in the p53 gene was 35% but the true frequency appears to be higher (up to 56%). In the K-ras gene, the mutation frequency (15%) was significantly lower than that reported for colon cancer. In the p53 gene, the mutation frequency increased significantly with patient age. In a high proportion of patients (14%) the rectal tumours contained small subclones of tumour cells that displayed extremely rare mutations at codons 110 and 232 of the p53 gene. Hot spot codon 175 mutations were significantly less common in rectal cancer than in cancer of the colon.
CONCLUSIONS: Rectal cancer among Finnish women has characteristics in the mutations of the p53 and K-ras genes that are uncommon in other human tumours, including cancer of the colon. A biological explanation of these findings is not clear at present, but might be associated with an unidentified genetic factor in Finland.

Entities:  

Mesh:

Year:  2000        PMID: 10884918      PMCID: PMC1186898          DOI: 10.1136/mp.53.1.24

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  18 in total

Review 1.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

2.  c-K-ras mutations in human carcinomas occur preferentially in codon 12.

Authors:  L Yanez; J Groffen; D M Valenzuela
Journal:  Oncogene       Date:  1987       Impact factor: 9.867

3.  K-ras and p53 mutations and overexpressions as prognostic factors in female rectal carcinoma.

Authors:  P Hirvikoski; A Auvinen; K Servomaa; A Kiuru; T Rytömaa; K Makkonen; V M Kosma
Journal:  Anticancer Res       Date:  1999 Jan-Feb       Impact factor: 2.480

Review 4.  Clinical implications of the p53 tumor-suppressor gene.

Authors:  C C Harris; M Hollstein
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

Review 5.  Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location.

Authors:  J A Bufill
Journal:  Ann Intern Med       Date:  1990-11-15       Impact factor: 25.391

6.  Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP).

Authors:  S Ichii; S Takeda; A Horii; S Nakatsuru; Y Miyoshi; M Emi; Y Fujiwara; K Koyama; J Furuyama; J Utsunomiya
Journal:  Oncogene       Date:  1993-09       Impact factor: 9.867

7.  Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer.

Authors:  S M Bell; N Scott; D Cross; P Sagar; F A Lewis; G E Blair; G R Taylor; M F Dixon; P Quirke
Journal:  Gastroenterology       Date:  1993-01       Impact factor: 22.682

8.  K-ras gene mutations in early colorectal cancer ... flat elevated vs polyp-forming cancer....

Authors:  H Hasegawa; M Ueda; M Watanabe; T Teramoto; M Mukai; M Kitajima
Journal:  Oncogene       Date:  1995-04-06       Impact factor: 9.867

Review 9.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

10.  K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location.

Authors:  J Breivik; G I Meling; A Spurkland; T O Rognum; G Gaudernack
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

View more
  19 in total

1.  Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort.

Authors:  Chaar Ines; Ounissi Donia; Boughriba Rahma; Azza Ben Ammar; Amara Sameh; Taher Khalfallah; Ben Hmida Abdelmajid; Mzabi Sabeh; Bouraoui Saadia
Journal:  Tumour Biol       Date:  2014-04-25

2.  Different patterns of DNA methylation of the two distinct O6-methylguanine-DNA methyltransferase (O6-MGMT) promoter regions in colorectal cancer.

Authors:  P Mokarram; M Zamani; S Kavousipour; F Naghibalhossaini; C Irajie; M Moradi Sarabi; S V Hosseini
Journal:  Mol Biol Rep       Date:  2012-12-28       Impact factor: 2.316

3.  p53 expression in colorectal carcinoma in relation to histopathological features in Ugandan patients.

Authors:  Peter F Rambau; Michael Odida; Henry Wabinga
Journal:  Afr Health Sci       Date:  2008-12       Impact factor: 0.927

4.  High frequency of genes' promoter methylation, but lack of BRAF V600E mutation among Iranian colorectal cancer patients.

Authors:  Fakhraddin Naghibalhossaini; Hamideh Mahmoodzadeh Hosseini; Pooneh Mokarram; Mozhdeh Zamani
Journal:  Pathol Oncol Res       Date:  2011-04-01       Impact factor: 3.201

5.  Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians.

Authors:  Pooja Malhotra; Mumtaz Anwar; Neha Nanda; Rakesh Kochhar; Jai Dev Wig; Kim Vaiphei; Safrun Mahmood
Journal:  Tumour Biol       Date:  2013-03-24

6.  TAp73 is one of the genes responsible for the lack of response to chemotherapy depending on B-Raf mutational status.

Authors:  Marta Herreros-Villanueva; Pilar Muñiz; Carlos García-Girón; Mónica Cavia-Saiz; María J Coma del Corral
Journal:  J Transl Med       Date:  2010-02-10       Impact factor: 5.531

7.  KRAS gene mutations in correlation with clinicopathological features of colorectal carcinomas in Indian patient cohort.

Authors:  Harshali Patil; Rajesh Korde; Arnab Kapat
Journal:  Med Oncol       Date:  2013-06-01       Impact factor: 3.064

8.  Colorectal carcinoma prognosis can be predicted by alterations in gene p53 exons 5 and 8.

Authors:  M Vidaurreta; M L Maestro; M T Sanz-Casla; S Rafael; S Veganzones; V de la Orden; J Cerdán; M Arroyo; A Torres
Journal:  Int J Colorectal Dis       Date:  2008-03-06       Impact factor: 2.571

9.  Comparison of risk factors for colon and rectal cancer.

Authors:  Esther K Wei; Edward Giovannucci; Kana Wu; Bernard Rosner; Charles S Fuchs; Walter C Willett; Graham A Colditz
Journal:  Int J Cancer       Date:  2004-01-20       Impact factor: 7.396

10.  Molecular gate keepers succumb to gene aberrations in colorectal cancer in Kashmiri population, revealing a high incidence area.

Authors:  A Syed Sameer; Shakeel ul Rehman; Arshad A Pandith; Nidda Syeed; Zaffar A Shah; Nissar A Chowdhri; Khursheed A Wani; Mushtaq A Siddiqi
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.